G.
It is hard to understand your English a little.
But I disagree with you on Macrilen. You are right the company did miss one of the end points from the FDA which apparently cost them an approval the first time. I believe the company is saying to the FDA that after going over all the info and having an independent source also check some things (like reproducibility and stimulation of the pituitary gland and ease of test and safety of test using the ITT as a comparative as the FDA did ) that they believe that Macrilen has so many positive aspects as compared to the insulin tolerance test that even with missing one end point they feel the product should get approved and move forward. Also the company said that with some fine tuning of dosage that they believe Macrilen can hit the end point it missed. So I believe the best they can hope for is approval of the product. Of course this does NOT mean they will get it but I believe they may. Just my opinion.
As far as the ATM I was half joking, but my intent was to say that if some one is willing to give them money than you would think that, the person offering the money would likely have some belief they are not just flushing it down the toilet. The company said they have over 20 million in cash now. So if nothing gets passed its irrelevant and I would be surprised if they remain viable with the limited amount of income they now have. So at the very least they need something positive or something kind of positive.
And I am hoping for a thumbs up not a thumbs down. Up is good down is bad.
I feel that if the FDA doesn't approve Zoptrex, they may want more info on it, delaying it and dragging us all along. Or they can just say yes. woohoo. Or no even though we love the safety profile of your product we don't believe there is enough proof that it is actually making some people better and keeping some people stable. That is what we have to wait for.
Which is why I am banking and hoping that they can get an approval on Macrilen because even if Zoptrex isn't a yes, Macrilen within a year or two can produce 50 to 100 million maybe more, annually which would keep the company going and viable until they can maybe get zoptrex approved or find something else. I feel they need to turn the corner now or they are in trouble.
Just my 2 cents on it. I do own stock and I am very nervous, like many others, while I wait to see what the next week and then month brings.
Good Luck
